Table 2.
Crude and adjusted associations between change in physical activity, cardiovascular disease risk factors and modelled cardiovascular disesae risk at follow-up in the ADDITION-Cambridge trial cohort
Women | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Outcome | Standardized β-coefficient* | ||||||||||||
Total cholesterol | 95% CI | P-value | Systolic blood pressure | 95% CI | P-value | HbA1c | 95% CI | P-value | Modelled cardiovascular disease risk§ | 95% CI | P-value | ||
Δ home physical activity | Crude | −0.042 | −0.15 to 0.063 | 0.43 | −1.42 | −3.63 to 0.98 | 0.21 | −0.044 | −0.14 to 0.049 | 0.35 | −0.004 | −0.014 to 0.006 | 0.39 |
(MET h/week) | Adjusted† | −0.030 | −0.11 to 0.056 | 0.49 | −1.50 | −3.41 to 0.41 | 0.12 | −0.030 | −0.11 to 0.048 | 0.45 | −0.003 | −0.010 to 0.003 | 0.33 |
Δ work physical activity‡ | Crude | −0.17 | −0.42 to 0.075 | 0.17 | 0.44 | −5.26 to 6.14 | 0.88 | −0.026 | −0.23 to 0.18 | 0.80 | −0.006 | −0.023 to 0.011 | 0.48 |
(MET h/week) | Adjusted† | −0.083 | −0.28 to 0.12 | 0.41 | 1.52 | −3.58 to 6.62 | 0.55 | 0.053 | −0.15 to 0.26 | 0.61 | 0.003 | −0.007 to 0.012 | 0.56 |
Δ recreational physicalactivity | Crude | −0.009 | −0.03 to 0.12 | 0.89 | −2.01 | −4.69 to 0.68 | 0.14 | 0.027 | −0.083 to 0.14 | 0.93 | −0.006 | −0.018 to 0.006 | 0.29 |
(MET h/week) | Adjusted† | −0.029 | −0.13 to 0.076 | 0.59 | −2.32 | −4.60 to −0.05 | 0.045 | 0.022 | −0.072 to 0.12 | 0.65 | −0.005 | −0.013 to 0.003 | 0.22 |
Δ vigorous physical activity | Crude | −0.14 | −0.39 to 0.10 | 0.25 | −4.39 | −9.44 to 0.66 | 0.088 | 0.020 | −0.19 to 0.24 | 0.85 | −0.016 | −0.039 to 0.007 | 0.16 |
(h/week) | Adjusted† | −0.15 | −0.34 to 0.050 | 0.14 | −2.49 | −6.83 to 1.85 | 0.26 | 0.023 | −0.16 to 0.21 | 0.80 | −0.003 | −0.018 to 0.012 | 0.71 |
Men | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Outcome | Standardized β-coefficient* | ||||||||||||
Total cholesterol | 95% CI | P-value | Systolic blood pressure | 95% CI | P-value | HbA1c | 95% CI | P-value | Modelled cardiovascular disease risk§ | 95% CI | P-value | ||
Δ home physical activity | Crude | −0.071 | −0.17 to 0.029 | 0.16 | −0.52 | −2.29 to 1.26 | 0.57 | −0.004 | −0.094 to 0.086 | 0.93 | −0.001 | −0.013 to 0.011 | 0.87 |
(MET h/week) | Adjusted† | −0.021 | −0.098 to 0.056 | 0.60 | −0.84 | −2.34 to 0.66 | 0.27 | 0.009 | −0.075 to 0.093 | 0.83 | −0.003 | −0.010 to 0.005 | 0.48 |
Δ work physical activity ‡c | Crude | −0.055 | −0.19 to 0.077 | 0.41 | −2.55 | −4.96 to −0.14 | 0.038 | −0.11 | −0.24 to 0.008 | 0.067 | −0.012 | −0.026 to 0.003 | 0.12 |
(MET h/week) | Adjusted† | −0.001 | −0.093 to 0.090 | 0.98 | −1.21 | −3.17 to 0.76 | 0.23 | −0.079 | −0.19 to 0.037 | 0.18 | −0.004 | −0.013 to 0.005 | 0.40 |
Δ recreational physical activity | Crude | 0.001 | −0.089 to 0.091 | 0.98 | 0.16 | −1.50 to 1.82 | 0.85 | −0.085 | −0.17 to 0.001 | 0.052 | −0.012 | −0.12 to 0.014 | 0.028 |
(MET h/week) | Adjusted† | 0.012 | −0.058 to 0.081 | 0.74 | 0.79 | −0.62 to 2.20 | 0.27 | −0.093 | −0.17 to −0.014 | 0.021 | −0.006 | −0.013 to 0.001 | 0.11 |
Δ vigorous physical activity | Crude | 0.069 | −0.008 to 0.15 | 0.079 | 0.90 | −0.48 to 2.29 | 0.20 | −0.035 | −0.11 to 0.036 | 0.33 | 0.003 | −0.006 to 0.012 | 0.53 |
(h/week) | Adjusted† | 0.029 | −0.031 to 0.089 | 0.35 | 0.56 | −0.60 to 1.73 | 0.34 | −0.033 | −0.099 to 0.033 | 0.33 | 0.001 | −0.005 to 0.007 | 0.67 |
For every standard deviation unit increase in [physical activity domain], there was an average [increase/decrease] of [XX] units in [cardiovascular disease risk factor].
Adjusted for baseline physical activity behaviour, age, randomization group, change in smoking, change in calorie intake and change in medication use (total cholesterol adjusted for change in lipid-lowering medication, systolic blood pressure adjusted for change in anti-hypertensive medication, HbA1c adjusted for glucose-lowering medication at 1 year, and modelled cardiovascular disease risk adjusted for change in lipid-lowering, anti-hypertensive medication and glucose-lowering medication at 1 year).
Includes only participants who had a job at baseline and after 1 year.
Calculated using the UK Prospective Diabetes Study (UKPDS) risk engine (version 3), excluding participants who experienced a previous heart attack or stroke.
MET, metabolic equivalent.